Case report 2: Fungal infections in chronic obstructive pulmonary disease.
Meersseman
Wouter
W
Department of General Internal Medicine and Intensive Care Medicine, University Hospital Gasthuisberg, Leuven, Belgium. wouter.meersseman@uz.kuleuven.ac.be
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage; D001232:Aspergillus fumigatus / Q000302:isolation & purification*; D001530:Belgium; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D055732:Pulmonary Aspergillosis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000188:drug therapy; D011743:Pyrimidines / Q000008:administration & dosage; D013902:Radiography, Thoracic; D013256:Steroids / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014230:Triazoles / Q000008:administration & dosage; D065819:Voriconazole
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D011743:Pyrimidines; D013256:Steroids; D014230:Triazoles; D065819:Voriconazole